You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Linagliptin

Showing 1 - 25 of 210
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Trial in Qingdao (Test Empagliflozin And Linagliptin Tablets, Reference Empagliflozin And Linagliptin tablets)

Completed
  • Healthy
  • Test Empagliflozin And Linagliptin Tablets
  • Reference Empagliflozin And Linagliptin tablets
  • Qingdao, Shandong, China
    The Affiliated Hospital of Qingdao University Phase I Clinical R
Jul 14, 2023

Diabetes, Kidney Transplant; Complications Trial (Empagliflozin 25 MG, Linagliptin 5 mg Oral Tablet)

Not yet recruiting
  • Diabetes Mellitus
  • Kidney Transplant; Complications
  • Empagliflozin 25 MG
  • Linagliptin 5 mg Oral Tablet
  • (no location specified)
Oct 18, 2023

Kidney Transplant; Complications, Diabetes Trial (Empagliflozin 25 MG, Linagliptin)

Not yet recruiting
  • Kidney Transplant; Complications
  • Diabetes Mellitus
  • Empagliflozin 25 MG
  • Linagliptin
  • (no location specified)
Oct 18, 2023

Healthy Subjects Trial in Cheongju-si (DW6013)

Completed
  • Healthy Subjects
  • Cheongju-si, Korea, Republic of
    Chungbuk National University Hospital
May 16, 2023

Healthy Subjects Trial in Cheongju-si (DW6013)

Completed
  • Healthy Subjects
  • Cheongju-si, Korea, Republic of
    Chungbuk National University Hospital
May 16, 2023

Polycystic Ovary Syndrome (PCOS) Trial in Alexandria (Empagliflozin 25 mg, Linagliptin 10 mg, Metformin 1500 mg)

Recruiting
  • Polycystic Ovary Syndrome (PCOS)
  • Empagliflozin 25 mg
  • +2 more
  • Alexandria, Egypt
    Alexandria University
Jan 14, 2022

PreDiabetes, Type 2 Diabetes Trial in Johor Bahru (Dipeptidyl-Peptidase IV Inhibitors)

Completed
  • PreDiabetes
  • Type 2 Diabetes
  • Dipeptidyl-Peptidase IV Inhibitors
  • Johor Bahru, Johor, Malaysia
    Hospital Sultan Ismail
Mar 13, 2022

Type 2 Diabetes Trial in Buffalo (Linagliptin, Placebo)

Completed
  • Type 2 Diabetes
  • Linagliptin
  • Placebo
  • Buffalo, New York
    ECMC Ambulatory Center, 3rd Floor
Feb 2, 2022

Type 2 Diabetes, Mild Cognitive Impairment Trial in Nanjing (Liraglutide, Empagliflozin, Linagliptin)

Recruiting
  • Type 2 Diabetes Mellitus
  • Mild Cognitive Impairment
  • Nanjing, Jiangsu, China
  • +1 more
Mar 28, 2022

Four Second Line Pharmacological Strategies in Type 2 Diabetes

Active, not recruiting
  • Cardiovascular Events
  • +2 more
  • SGLT2 inhibitor
  • +3 more
  • Boston, Massachusetts
    Brigham and Women's Hospital
Feb 17, 2022

Type2 Diabetes Trial in Amsterdam (EMPA/LINA 10/5 mg QD (n=22), LINA/EMPA 5/10 mg QD (N=22), Gliclazide 30 mg QD/BID (N=22))

Active, not recruiting
  • Type2 Diabetes
  • EMPA/LINA 10/5 mg QD (n=22)
  • +2 more
  • Amsterdam, Noord-Holland, Netherlands
    VU University Medical Center
Jan 13, 2022

Liver Cirrhosis, Diabetes Trial in Shanghai (Insulin Degludec and Insulin Aspart)

Recruiting
  • Liver Cirrhosis
  • Diabetes
  • Insulin Degludec and Insulin Aspart
  • Shanghai, Shanghai, China
    Xiaolong Zhao
Nov 29, 2022

Type 2 Diabetes Trial in Hortolândia (LID104, Dapagliflozin, Linagliptin)

Not yet recruiting
  • Type 2 Diabetes Mellitus
  • Hortolândia, SP, Brazil
    Investigational site
May 23, 2023

(PMS) in Korean Patients With Type 2 Diabetes Mellitus

Recruiting
  • Diabetes Mellitus, Type 2
  • Cheonan-si, Cheonan-si, Chungcheongnam-do, Korea, Republic of
  • +2 more
Jul 26, 2022

Cognitive Protective Effect of Newer Antidiabetic Drugs

Recruiting
  • Type 2 Diabetes
  • Alexandria, Egypt
    Alexandria University
Jul 24, 2022

Diabetes Trial in Seoul (FCDP, dapagliflozin 10mg/linagliptin 5 mg or co-administration of a single dose of dapagliflozin and

Completed
  • Diabetes Mellitus
  • FCDP, dapagliflozin 10mg/linagliptin 5 mg or co-administration of a single dose of dapagliflozin and linagliptin
  • Seoul, Korea, Republic of
    Korea University Anam Hospital
Sep 24, 2021

Type II Diabetes in Subjects BMI 27 to 32 Trial in Singapore (Roux-en-Y Gastric Bypass (RYGB), Incretin analogues, Xenical)

Completed
  • Type II Diabetes in Subjects BMI 27 to 32
  • Roux-en-Y Gastric Bypass (RYGB)
  • +4 more
  • Singapore, Singapore
    Khoo Teck Puat Hospital
Jun 22, 2022

COVID 19, Coronavirus, Diabetes, Type 2 Trial in Be'er Ya'aqov, Petah tikva (Linagliptin 5 MG)

Terminated
  • COVID 19
  • +14 more
  • Linagliptin 5 MG
  • Be'er Ya'aqov, Israel
  • +2 more
May 28, 2021

Schizophrenia Trial in Reno (Linagliptin)

Completed
  • Schizophrenia
  • Linagliptin
  • Reno, Nevada
    University of Nevada School of Medicine
Nov 5, 2020

Coronavirus Infection, Type 2 Diabetes Trial in Miami (Linagliptin, Insulin regimen)

Withdrawn
  • Coronavirus Infection
  • Type 2 Diabetes
  • Linagliptin
  • Insulin regimen
  • Miami, Florida
    University of Miami
Jun 7, 2021

Diabetes, Type 2, Left Ventricular Systolic Dysfunction Trial in Italy (Linagliptin, Placebo)

Completed
  • Diabetes Mellitus, Type 2
  • Left Ventricular Systolic Dysfunction
  • Linagliptin
  • Placebo
  • Bergamo, BG, Italy
  • +18 more
May 21, 2021

Comparison of Type 2 Diabetes Pharmacotherapy Regimens

Recruiting
  • Type 2 Diabetes Mellitus
  • Cardiovascular Diseases
  • Oakland, California
  • +5 more
Oct 18, 2022

SGLT-2 and DPP-4 Inhibition, Subclinical Inflammation of

Unknown status
  • Type 2 Diabetes
  • Urinary Tract Infections
  • Empagliflozin / Linagliptin or Dapagliflozin/Saxagliptin Pill
  • Empagliflozin or Dapagliflozin Pill
  • Pisa, Italy
    University of Pisa
Jan 27, 2021

Hyperglycemia, Covid19 Trial in Leòn (Linagliptin tablet, Insulin)

Completed
  • Hyperglycemia
  • Covid19
  • Leòn, Guanajuato, Mexico
    Hospital Regional de Alta Especialidad del Bajìo
Mar 19, 2021

Diabetes, Type 2 Trial in Worldwide (Linagliptin, Empagliflozin, Placebo)

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • Linagliptin
  • +2 more
  • Phoenix, Arizona
  • +82 more
Aug 23, 2022